CONCLUSION
In summary, our study suggests that longitudinal changes in maternal sFlt-1 levels from admission for confirmed PE add to baseline characteristics in predicting maternal complications and interval to delivery. Further studies are needed to evaluate the evolution of angiogenic factors levels at fixed time points after admission and to address the impact of incorporating this parameter in the clinical management of early-onset PE on maternal and fetal outcomes.